Ninčević, V.; Zjalić, M.; Kolarić, T.O.; Smolić, M.; Kizivat, T.; Kuna, L.; Včev, A.; Tabll, A.; Ćurčić, I.B.
Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy. Curr. Issues Mol. Biol. 2022, 44, 1087-1114.
https://doi.org/10.3390/cimb44030072
AMA Style
Ninčević V, Zjalić M, Kolarić TO, Smolić M, Kizivat T, Kuna L, Včev A, Tabll A, Ćurčić IB.
Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy. Current Issues in Molecular Biology. 2022; 44(3):1087-1114.
https://doi.org/10.3390/cimb44030072
Chicago/Turabian Style
Ninčević, Vjera, Milorad Zjalić, Tea Omanović Kolarić, Martina Smolić, Tomislav Kizivat, Lucija Kuna, Aleksandar Včev, Ashraf Tabll, and Ines Bilić Ćurčić.
2022. "Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy" Current Issues in Molecular Biology 44, no. 3: 1087-1114.
https://doi.org/10.3390/cimb44030072
APA Style
Ninčević, V., Zjalić, M., Kolarić, T. O., Smolić, M., Kizivat, T., Kuna, L., Včev, A., Tabll, A., & Ćurčić, I. B.
(2022). Renoprotective Effect of Liraglutide Is Mediated via the Inhibition of TGF-Beta 1 in an LLC-PK1 Cell Model of Diabetic Nephropathy. Current Issues in Molecular Biology, 44(3), 1087-1114.
https://doi.org/10.3390/cimb44030072
